Deconstruction of Heterogeneity of Size-Dependent Exosome Subpopulations from Human Urine by Profiling N-Glycoproteomics and Phosphoproteomics Simultaneously
- PMID: 32495629
- DOI: 10.1021/acs.analchem.0c01572
Deconstruction of Heterogeneity of Size-Dependent Exosome Subpopulations from Human Urine by Profiling N-Glycoproteomics and Phosphoproteomics Simultaneously
Abstract
The heterogeneous populations of exosomes with distinct nanosize have impeded our understanding of their corresponding function as intercellular communication agents. Profiling signaling proteins packaged in each size-dependent subtype can disclose this heterogeneity of exosomes. Herein, new strategy was developed for deconstructing heterogeneity of distinct-size urine exosome subpopulations by profiling N-glycoproteomics and phosphoproteomics simultaneously. Two-dimension size exclusion liquid chromatography (SEC) was utilized to isolate large exosomes (L-Exo), medium exosomes (M-Exo), and small exosomes (S-Exo) from human urine samples. Then, hydrophilic carbonyl-functionalized magnetic zirconium-organic framework (CFMZOF) was developed as probe for capturing the two kinds of post-translational modification (PTM) peptides simultaneously. Finally, liquid chromatography-tandem mass spectrometry (LC-MS/MS) combined with database search was used to characterize PTM protein contents. We identified 144 glycoproteins and 44 phosphoproteins from L-Exo, 156 glycoproteins, and 46 phosphoproteins from M-Exo and 134 glycoproteins and 10 phosphoproteins from S-Exo. The ratio of the proteins with simultaneous glycosylation and phosphorylation is 11%, 9%, and 3% in L-Exo, M-Exo, and S-Exo, respectively. Based on label-free quantification intensity results, both principal component analysis and Pearson's correlation coefficients indicate that distinct-size exosome subpopulations exist significant differences in PTM protein contents. Analysis of high abundance PTM proteins in each exosome subset reveals that the preferentially packaged PTM proteins in L-Exo, M-Exo, and S-Exo are associated with immune response, biological metabolism, and molecule transport processes, respectively. Our PTM proteomics study based on size-dependent exosome subtypes opens a new avenue for deconstructing the heterogeneity of exosomes.
Similar articles
-
[Isolation and proteomics analysis of cerebrospinal fluid exosome subtypes].Se Pu. 2025 May;43(5):518-528. doi: 10.3724/SP.J.1123.2024.10014. Se Pu. 2025. PMID: 40331615 Free PMC article. Chinese.
-
TIMAHAC: Streamlined Tandem IMAC-HILIC Workflow for Simultaneous and High-Throughput Plant Phosphoproteomics and N-glycoproteomics.Mol Cell Proteomics. 2024 May;23(5):100762. doi: 10.1016/j.mcpro.2024.100762. Epub 2024 Apr 11. Mol Cell Proteomics. 2024. PMID: 38608839 Free PMC article.
-
Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation.Nat Cell Biol. 2018 Mar;20(3):332-343. doi: 10.1038/s41556-018-0040-4. Epub 2018 Feb 19. Nat Cell Biol. 2018. PMID: 29459780 Free PMC article.
-
Strategies for analysis of glycoprotein glycosylation.Biochim Biophys Acta. 2006 Dec;1764(12):1853-69. doi: 10.1016/j.bbapap.2006.10.007. Epub 2006 Oct 24. Biochim Biophys Acta. 2006. PMID: 17134948 Review.
-
Recent advances and challenges in plant phosphoproteomics.Proteomics. 2015 Mar;15(5-6):1127-41. doi: 10.1002/pmic.201400410. Epub 2015 Jan 21. Proteomics. 2015. PMID: 25429768 Review.
Cited by
-
Extracellular Vesicle Characteristics in Local Fluid and Plasma Measured by Nanoparticle Tracking Analysis Can Help Differentiate High-Grade Serous Carcinoma from Benign Ovarian Pathology.Diagnostics (Basel). 2024 Oct 7;14(19):2235. doi: 10.3390/diagnostics14192235. Diagnostics (Basel). 2024. PMID: 39410639 Free PMC article.
-
Recent Progress of Exosome Isolation and Peptide Recognition-Guided Strategies for Exosome Research.Front Chem. 2022 Feb 24;10:844124. doi: 10.3389/fchem.2022.844124. eCollection 2022. Front Chem. 2022. PMID: 35281563 Free PMC article. Review.
-
The Landscape of Exosomes Biogenesis to Clinical Applications.Int J Nanomedicine. 2024 Apr 22;19:3657-3675. doi: 10.2147/IJN.S463296. eCollection 2024. Int J Nanomedicine. 2024. PMID: 38681093 Free PMC article. Review.
-
Emerging technologies towards extracellular vesicles large-scale production.Bioact Mater. 2025 Jun 13;52:338-365. doi: 10.1016/j.bioactmat.2025.06.005. eCollection 2025 Oct. Bioact Mater. 2025. PMID: 40585384 Free PMC article. Review.
-
Clinical Application of Small Extracellular Vesicles in Gynecologic Malignancy Treatments.Cancers (Basel). 2023 Mar 26;15(7):1984. doi: 10.3390/cancers15071984. Cancers (Basel). 2023. PMID: 37046644 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources